JP2025506248A5 - - Google Patents

Info

Publication number
JP2025506248A5
JP2025506248A5 JP2024548730A JP2024548730A JP2025506248A5 JP 2025506248 A5 JP2025506248 A5 JP 2025506248A5 JP 2024548730 A JP2024548730 A JP 2024548730A JP 2024548730 A JP2024548730 A JP 2024548730A JP 2025506248 A5 JP2025506248 A5 JP 2025506248A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
antibody
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024548730A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025506248A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/077493 external-priority patent/WO2023155925A1/en
Publication of JP2025506248A publication Critical patent/JP2025506248A/ja
Publication of JP2025506248A5 publication Critical patent/JP2025506248A5/ja
Pending legal-status Critical Current

Links

JP2024548730A 2022-02-21 2023-02-21 抗５ｔ４抗体およびその使用 Pending JP2025506248A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2022077113 2022-02-21
CNPCT/CN2022/077113 2022-02-21
PCT/CN2023/077493 WO2023155925A1 (en) 2022-02-21 2023-02-21 Anti-5t4 antibodies and uses thereof

Publications (2)

Publication Number Publication Date
JP2025506248A JP2025506248A (ja) 2025-03-07
JP2025506248A5 true JP2025506248A5 (https=) 2026-01-22

Family

ID=87577641

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024548730A Pending JP2025506248A (ja) 2022-02-21 2023-02-21 抗５ｔ４抗体およびその使用

Country Status (8)

Country Link
US (1) US20250154277A1 (https=)
EP (2) EP4736958A2 (https=)
JP (1) JP2025506248A (https=)
KR (2) KR20260033116A (https=)
CN (1) CN118946590A (https=)
AU (2) AU2023220523A1 (https=)
CA (1) CA3250452A1 (https=)
WO (1) WO2023155925A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20260008868A1 (en) * 2024-07-05 2026-01-08 Solve Therapeutics, Inc. 5t4-binding proteins
CN119192356B (zh) * 2024-09-29 2025-05-27 华中农业大学 识别犬瘟热病毒h蛋白的单克隆抗体、检测试纸条及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SV2007002227A (es) * 2004-09-10 2007-03-20 Wyeth Corp Anticuerpos anti-5t4 humanizados y conjugados anticuerpo anti-5t4/calicheamicina ref. 040000-0317637
DK2368914T3 (en) * 2006-03-10 2019-03-04 Wyeth Llc Anti-5T4 antibodies and uses thereof
WO2012131527A1 (en) * 2011-04-01 2012-10-04 Wyeth Llc Antibody-drug conjugates
WO2014137931A1 (en) * 2013-03-06 2014-09-12 Imaginab, Inc. Antigen binding constructs to 5t4
AU2016358854B2 (en) * 2015-11-24 2023-02-02 Byondis B.V. Anti-5T4 antibodies and antibody-drug conjugates
CN108285487B (zh) * 2017-01-08 2021-02-19 浙江昭华生物医药有限公司 抗5t4抗体-药物偶联物及其应用

Similar Documents

Publication Publication Date Title
JP7763230B2 (ja) Ｃｄ４７に対するヒト化及びキメラモノクローナル抗体
CN112646031B (zh) 抗4-1bb纳米抗体及其用途
JP2023511774A5 (https=)
AU2026200768A1 (en) Tem8 antibodies and their use
AU2011336650B2 (en) Chimeric rabbit/human ROR1 antibodies
IL268745A (en) Antibody drug conjugates (adc) that bind to 158p1d7 proteins
JP2022101693A5 (https=)
JP2011501656A5 (https=)
JP2011509245A5 (https=)
JP2022513420A5 (https=)
JP2023549537A5 (https=)
JP2024501894A5 (https=)
JP2022553922A5 (https=)
CN115427449A (zh) 抗Gal3抗体和使用方法
JP2017526339A5 (https=)
JP2024537323A5 (https=)
JP2014524902A5 (https=)
TWI845724B (zh) 用於偶聯的多肽複合物及其應用
JP2020500834A5 (https=)
JP2019507580A5 (https=)
JP2024532489A5 (https=)
JP2025506248A5 (https=)
JP2019505166A5 (https=)
JP2022512647A5 (https=)
JP2023548529A5 (https=)